Improving Outcomes in Diabetic Macular Edema: The Impact of New Therapies in Managed Care

August 1, 2016

Publishing Staff

Publishing Staff

President, Managed Markets, Pharmacy, and Rare Disease

Brian Haug

Senior Vice President of Operations and Clinical Affairs

Jeff D. Prescott, PharmD, RPh

Senior Clinical Projects Manager

Ida Delmendo

Clinical Projects Manager

Cindy Spielvogel

Project Manager

Jessica Toye


Griselda Demassey

Maggie Shaw

Associate Editor

Jeanne Linke

Assistant Editor

Sarah Anwar

Clinical Editor

Michael R. Page, PharmD, RPh


Julianne Costello

Associate Publisher

Justin T. Gallagher

Director of Sales

Sara Belanger

National Account Managers

Gabrielle Consola

Michael Costella


Chairman and CEO

Mike Hennessy, Sr

Vice Chairman

Jack Lepping


Mike Hennessy, Jr

Chief Operating Officer/CFO

Neil Glasser, CPA/CFE

Executive Vice President and General Manager

John Maglione

Chief Marketing Officer

Warren Dardine

Vice President of Editorial Services and Production

Kerrie Keegan

Vice President, Digital Media

Jung Kim

Chief Creative Officer

Jeff Brown

Human Resources Director

Shari Lundenberg

President, Pharmacy Times Continuing Education

David Heckard

Copyright © 2016 by Managed Care & Healthcare Communications, LLC


Seenu M. Hariprasad, MD

Shui-Chin Lee Professor in Ophthalmology

Chief, Vitreoretinal Service

Director, Clinical Research

Director, Fellowship in the Diseases and Surgery of the Retina,

Macula and Vitreous

University of Chicago

Chicago, Illinois

Nancy M. Holekamp, MD


Retina Services

Pepose Vision Institute

Chesterfield, Missouri

Clinical Professor

Department of Ophthalmology

Washington University

Saint Louis, Missouri

Editorial Support

Jill E. Allen, PharmD, BCPS

Drug Information Consultant

Pin Oak Associates

Salt Lake City, Utah

Michelle Dalton, ELS


Dalton & Associates

Reading, Pennsylvania

Debra Gordon


GordonSquared, Inc.

Williamsburg, Virginia

Faculty Disclosures

Seenu M. Hariprasad, MD,

has the following relevant financial relationships with commercial interests to disclose:

Consultant or speakers bureau:

Alcon, Alimera Sciences, Allergan, Bayer, Biomedical, Clearside, Janssen, Ocular Therapeutics, OD-OS, Optos, Regeneron, Spark

Nancy M. Holekamp, MD,

has the following relevant financial relationships with commercial interests to disclose:

Grant/research support:

Alimera Sciences, Allergan, Genentech, Neurotech, Opthotech


Alimera Sciences, Allergan, Genentech, Katalyst, Regeneron

Speakers bureau:

Alimera Sciences, Allergan, Genentech, Regeneron



Editorial Support Disclosures

Jill E. Allen, PharmD, BCPS,

Debra Gordon

and have no relevant financial relationships with commercial interests to disclose.

Michelle Dalton, ELS,

has the following relevant disclosure with commercial interests to disclose:

Medical writer:

Bayer Healthcare

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Cindy Spielvogel have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education

Planning Staff—Dave Heckard; Maryjo Dixon, RPh; Neelam Davis, PharmD; Donna Fausak; and Tara DeLorenzo have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy

According to the disclosure policy of The American Journal of Managed Care and Pharmacy Times Continuing Education, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Pharmacy Times Continuing Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Disclosure of Unapproved/Off-Label Use

The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Continuing Education, or any of the companies that provided commercial support for this CE activity.